Cite Filings / AVTX / 0001628280-19-001160

Feed Companies Filings Check

Sign in

424B3

Prospectus

Avalo Therapeutics, Inc. Filed 2019-02-11 Acc 0001628280-19-001160

Documents 1

424B3 Prospectus , a424b3prospectus-registrat.htm

Around this filing

2019-10-25 424B3 Prospectus
2019-02-14 SC 13G/A Amended Statement of Ownership
2019-02-11 EFFECT Notice of Effectiveness
2019-02-11 424B3 Prospectus
2019-02-08 UPLOAD SEC-generated Letter
2019-02-07 CORRESP Correspondence Between Filers and SEC Staff
2018-10-05 424B3 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading a424b3prospectus-registrat.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…